Profiling brain and plasma lipids in human apoe ε2, ε3, and ε4 knock - In mice using electrospray ionization mass spectrometry

Journal of Alzheimer's Disease

Volumn 20, Issue 1, 2010, Pages 105-111

  Sharman, Matthew J ^a,b   Shui, Guanghou ^c   Fernandis, Aaron Z ^c   Lim, Wei Ling F ^b,d   Berger, Tamar ^b,d   Hone, Eugene ^b,d   Taddei, Kevin ^a,b,d   Martins, Ian J ^a,b   Ghiso, Jorge ^e   Buxbaum, Joseph D ^f   Gandy, Sam ^f   Wenk, Markus R ^c   Martins, Ralph N ^a,b,d  

^a EDITH COWAN UNIVERSITY   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; APOE genotype; cholesterol; glycerophospholipids; lipidomics; sphingolipids

Indexed keywords

APOENZYME; APOENZYME EPSILON2; APOENZYME EPSILON3; APOENZYME EPSILON4; CERAMIDE; CHOLESTEROL; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; SPHINGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; GENOTYPE; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 77954465016     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1348     Document Type: Article

References (50)

1. Lin CT, Xu YF, Wu JY, Chan L (1986) Immunoreactive apolipoprotein E is a widely distributed cellular protein. Immunohistochemical localization of apolipoprotein E in baboon tissues. J Clin Invest 78, 947-958.
2. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
3. Cedazo-Minguez A, Cowburn RF (2001) Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J Cell Mol Med 5, 254-266.
4. Zannis VI, Just PW, Breslow JL (1981) Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 33, 11-24.
5. Lane RM, Farlow MR (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 46, 949-968.
6. DeMattos RB, Brendza RP, Heuser JE, Kierson M, Cirrito JR, Fryer JD (2001) Purification and characterization of astrocytesecreted apolipoprotein E and J-containing lipoproteins from wild type and human apo E transgenic mice. Neurochem Int 39, 415-425.
7. Koch S, Donarski N, Goetze K, Kreckel M, Stuerenberg HJ, Buhmann C, Beisiegel U (2001) Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res 42, 1143-1151.
8. Strittmatter WJ, Roses AD (1996) Apolipoprotein E and Alzheimer's disease. Annual Rev Neurosci 19, 53-77.
9. Weisgraber KH, Mahley RW(1996) Human apolipoprotein E: the Alzheimer's disease connection. FASEB J 10, 1485-1494.
10. Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R (1996) Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease. Ann N Y Acad Sci 802, 6-15.
11. Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D, Marcova L (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17, 516-529.
12. Adibhatla RM, Hatcher JF (2008) Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49, 241-268.
13. Igbavboa U, Hamilton J, Kim HY, Sun GY,Wood WG (2002) A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes. J Neurochem 80, 255-261.
14. Mahley RW, Rall SC, Jr. (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1, 507-537.
15. Laws SM, Hone E, Gandy S, Martins RN (2003) Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 84, 1215-1236.
16. Han X (2004) The role of apolipoprotein E in lipid metabolism in the central nervous system. Cell Mol Life Sci 61, 1896-1906.
17. Weisgraber KH, Roses AD, Strittmatter WJ (1994) The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 5, 110-116.
18. Han X, Fagan AM, Cheng H, Morris JC, Xiong C, Holtzman DM (2003) Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Ann Neurol 54, 115-119.
19. Maxfield FR, Tabas I (2005) Role of cholesterol and lipid organization in disease. Nature 438, 612-621.
20. Knouff C, Hinsdale ME, Mezdour H, Altenburg MK, Watanabe M, Quarfordt SH, Sullivan PM, Maeda N (1999) Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J Clin Invest 103, 1579-1586.
21. Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N(1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272, 17972-17980.
22. Sullivan PM, Mezdour H, Quarfordt SH, MaedaN(1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse ApoE with human ApoE*2. J Clin Invest 102, 130-135.
23. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of Mice Carrying a Mutant Apolipoprotein E Gene Inactivated by Gene Targeting in Embryonic Stem Cells. Proc Natl Acad Sci U S A 89, 4471-4475.
24. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
25. Wenk MR, Lucast L, Di Paolo G, Romanelli AJ, Suchy SF, Nussbaum RL, Cline GW, Shulman GI, McMurray W, De Camilli P (2003) Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry. Nat Biotechnol 21, 813-817.
26. Shui G, Bendt AK, Pethe K, Dick T, Wenk MR (2007) Sensitive profiling of chemically diverse bioactive lipids. J Lipid Res 48, 1976-1984.
27. Lee LH, Shui G, Farooqui AA, Wenk MR, Tan CH, Ong WY (2009) Lipidomic analyses of the mouse brain after antidepressant treatment: evidence for endogenous release of long-chain fatty acids? Int J Neuropsychopharmacol 12, 953-964.
28. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, Wenk MR (2008) Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J Virol 82, 11228-11238.
29. Fei W, Shui G, Gaeta B, Du X, Kuerschner L, Li P, Brown AJ,Wenk MR, Parton RG, Yang H (2008) Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast. J Cell Biol 180, 473-482.
30. Low CP, Shui G, Liew LP, Buttner S, Madeo F, Dawes IW, Wenk MR, Yang H (2008) Caspase-dependent and - independent lipotoxic cell-death pathways in fission yeast. J Cell Sci 121, 2671-2684.
31. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1-21.
32. Plump AS, Breslow JL (1995) Apolipoprotein E and the apolipoprotein E-deficient mouse. Ann Rev Nutrition 15, 495-518.
33. de Chaves EP, Narayanaswami V(2008) Apolipoprotein E and cholesterol in aging and disease in the brain. Future Lipidol 3, 505-530.
34. Hamanaka H, Katoh-Fukui Y, Suzuki K, Kobayashi M, Suzuki R, Motegi Y, Nakahara Y, Takeshita A, Kawai M, Ishiguro K, Yokoyama M, Fujita SC (2000) Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. Hum Mol Genet 9, 353-361.
35. Igbavboa U, Eckert GP, Malo TM, Studniski AE, Johnson LNA, Yamamoto N, Kobayashi M, Fujita SC, Appel TR, Muller WE,Wood WG, Yanagisawa K (2005) Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human ApoE 3 and 4 and by increasing age. J Neurol Sci 229-230, 225-232.
36. Han X, Cheng H, Fryer JD, Fagan AM, Holtzman DM (2003) Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. J Biol Chem 278, 8043-8051.
37. Rapp A, Gmeiner B, Huttinger M(2006) Implication of ApoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes. Biochimie 88, 473-483.
38. Michikawa M, Fan QW, Isobe I, Yanagisawa K (2000) Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem 74, 1008-1016.
39. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, PappollaMA(2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7, 321-331.
40. Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE (2001) A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 8, 890-899.
41. Pfrieger FW (2003) Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 60, 1158-1171.
42. Landen M, Hesse C, Fredman P, Regland B, Wallin A, Blennow K (1996) Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the ApoE4 isoform. Dementia 7, 273-278.
43. Blennow K, Hesse C, Fredman P (1994) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport 5, 2534-2536.
44. Hesse C, Larsson H, Fredman P, Minthon L, Andreasen N, Davidsson P, Blennow K (2000) Measurement of apolipoprotein E (ApoE) in cerebrospinal fluid. Neurochem Res 25, 511-517.
45. Lefranc D, Vermersch P, Dallongeville J, Daems-Monpeurt C, Petit H, Delacourte A (1996) Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. Neurosci Lett 212, 91-94.
46. Merched A, Blain H, Visvikis S, Herbeth B, Jeandel C, Siest G (1997) Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. J Neurol Sci 145, 33-39.
47. Lindh M, Blomberg M, Jensen M, Basun H, Lannfelt L, Engvall B, Scharnagel H, Marz W, Wahlund LO, Cowburn RF (1997) Cerebrospinal fluid apolipoprotein E (ApoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein. Neurosci Lett 229, 85-88.
48. Song H, Saito K, Seishima M, Noma A, Urakami K, Nakashima K (1997) Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease. Neurosci Lett 231, 175-178.
49. Demeester N, Castro G, Desrumaux C, De Geitere C, Fruchart JC, Santens P (2000) Characterization and functional studies of lipoproteins, lipid transfer proteins, lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J Lipid Res 41, 963-974.
50. Bandaru VV, Troncoso J, Wheeler D, Pletnikova O, Wang J, Conant K, Haughey NJ (2009) ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain. Neurobiol Aging 30, 591-599.